Structural modeling of disoxaril analogs reveals that molecule length and aliphatic chain flexibility dictate binding efficacy to human rhinovirus types 14 and 1A.
Authors
No takes yet. Share an insight, caveat, or question.
May inform HRV capsid inhibitor design; leaves open clinical translation from animal data.
Mallamo et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: